inhaled dose of COV Pars vaccine

2022-05-16 17:58

Preclinical studies of Cov Pars vaccine published by prestigious journal

TEHRAN – The preclinical studies on the Razi Cov Pars vaccine have been published in the Frontiers in Immunology as one of the world’s leading journals of immunology.
2021-10-12 17:53

Nasal dose of COV Pars reduces virus transmission by 90%

TEHRAN – The inhaled dose of COV Pars vaccine reduces the transmission of delta and alpha coronavirus variants by up to 90 percent, Ali Es’haqi, head of Razi Vaccine and Serum Institute, has said.